Literature DB >> 16695593

COMPARISON OF THE CONSTANT INFUSION AND URINE COLLECTION TECHNIQUES FOR THE MEASUREMENT OF RENAL FUNCTION.

E Y Berger1, S J Farber, D P Earle, R Jackenthal.   

Abstract

Year:  1948        PMID： 16695593      PMCID： PMC439547          DOI： 10.1172/JCI102020

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  4 in total

1.  THE MEASUREMENT OF THE TUBULAR EXCRETORY MASS, EFFECTIVE BLOOD FLOW AND FILTRATION RATE IN THE NORMAL HUMAN KIDNEY.

Authors:  H W Smith; W Goldring; H Chasis
Journal:  J Clin Invest       Date:  1938-05       Impact factor: 14.808

2.  DEPRESSION OF THE EXOGENOUS CREATININE/INULIN OR THIOSULFATE CLEARANCE RATIOS IN MAN BY DIODRAST AND p-AMINOHIPPURIC ACID.

Authors:  B Crawford
Journal:  J Clin Invest       Date:  1948-03       Impact factor: 14.808

3.  THE RENAL CLEARANCES OF SUBSTITUTED HIPPURIC ACID DERIVATIVES AND OTHER AROMATIC ACIDS IN DOG AND MAN.

Authors:  H W Smith; N Finkelstein; L Aliminosa; B Crawford; M Graber
Journal:  J Clin Invest       Date:  1945-05       Impact factor: 14.808

4.  THE CONTROL OF RENAL BLOOD FLOW AND GLOMERULAR FILTRATION IN NORMAL MAN.

Authors:  H Chasis; H A Ranges; W Goldring; H W Smith
Journal:  J Clin Invest       Date:  1938-09       Impact factor: 14.808
  4 in total
  14 in total

1.  THE MEASUREMENT OF EXTRACELLULAR FLUID IN MAN BY MEANS OF A CONSTANT INFUSION TECHNIQUE.

Authors:  I L Schwartz; D Schachter; N Freinkel
Journal:  J Clin Invest       Date:  1949-09       Impact factor: 14.808

2.  COMPARISON OF THE VOLUME OF DISTRIBUTION, RENAL AND EXTRARENAL CLEARANCES OF INULIN AND MANNITOL IN MAN.

Authors:  I L Schwartz; E S Breed; M H Maxwell
Journal:  J Clin Invest       Date:  1950-05       Impact factor: 14.808

3.  Angiotensin II utilizes Janus kinase 2 in hypertension, but not in the physiological control of blood pressure, during low-salt intake.

Authors:  Amy K L Banes-Berceli; Hind Al-Azawi; Daniel Proctor; Harvey Qu; Dominic Femminineo; Crystal Hill-Pyror; R Clinton Webb; Michael W Brands
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-08-03       Impact factor: 3.619

4.  Determination of inulin clearance by bolus intravenous injection in healthy subjects and ascitic patients: equivalence of systemic and renal clearances as glomerular filtration markers.

Authors:  R Orlando; M Floreani; R Padrini; P Palatini
Journal:  Br J Clin Pharmacol       Date:  1998-12       Impact factor: 4.335

Review 5.  Measurement of renal function in patients with chronic kidney disease.

Authors:  Euan A Sandilands; Neeraj Dhaun; James W Dear; David J Webb
Journal:  Br J Clin Pharmacol       Date:  2013-10       Impact factor: 4.335

6.  Measurement of glomerular filtration rate by inulin clearance without urine collection.

Authors:  G A Rose
Journal:  Br Med J       Date:  1969-04-12

7.  The normal increase in insulin after a meal may be required to prevent postprandial renal sodium and volume losses.

Authors:  Debra L Irsik; Bonnie L Blazer-Yost; Alexander Staruschenko; Michael W Brands
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-03-22       Impact factor: 3.619

8.  NADPH oxidase contributes to renal damage and dysfunction in Dahl salt-sensitive hypertension.

Authors:  Niu Tian; Rebecca S Moore; William E Phillips; Lin Lin; Sharkeshia Braddy; Janelle S Pryor; Rachel L Stockstill; Michael D Hughson; R Davis Manning
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-10-15       Impact factor: 3.619

9.  The concentration-dependent disposition of intravenous p-aminohippurate in subjects with normal and impaired renal function.

Authors:  L F Prescott; S Freestone; J A McAuslane
Journal:  Br J Clin Pharmacol       Date:  1993-01       Impact factor: 4.335

10.  Continuously measured renal blood flow does not increase in diabetes if nitric oxide synthesis is blocked.

Authors:  Tracy D Bell; Gerald F DiBona; Rachel Biemiller; Michael W Brands
Journal:  Am J Physiol Renal Physiol       Date:  2008-08-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.